// App-Quantinova.ai

231 : In Indigenous North Americans at High Risk for RA Complement C5 Level is Associated with ACPA Positivity and C5a with Transition to Synovitis even after Correcting for in Vitro Complement Activation Found with Prolonged Sample Storage

Researchers

Presenter

  • Carol Hitchon

Principal Investigators

  • Xiaobo Meng

  • Irene Smolik

  • David Robinson

  • Hani El-Gabalawy

Medical Centers

  • Univ of Manitoba, Winnipeg, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Complement Component 5a

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved